CS
ASTX

Credit Suisse’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History

Credit Suisse’s Portfolio ASTX Stock Details ASTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-699,208
Closed -$5.94M – 4854
2013
Q3 		$5.94M Buy
699,208
+515,804
+281% +$3.26M 0.01% 1498
2013
Q2 		$754K Buy
+183,404
New +$986K ﹤0.01% 3014

Credit Suisse's ASTX Position: Q4 2013 in Review

Credit Suisse sold out of ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q4 2013, closing a stake of 699,208 shares — an estimated $5.94M sold.

Credit Suisse first reported a position in ASTX in Q2 2013 and held it in 2 quarters. The position peaked at $5.94M in Q3 2013. 0 funds tracked by Wall St. Rank hold ASTX as of Q4 2013.

  • Credit Suisse reported no remaining ASTEX PHARMACEUTICALS, INC COM position as of Q4 2013 after selling out during the quarter.
  • Credit Suisse sold 699,208 ASTEX PHARMACEUTICALS, INC COM shares in Q4 2013, an estimated $5.94M.
  • Credit Suisse first reported a position in ASTEX PHARMACEUTICALS, INC COM in Q2 2013 and held it in 2 quarters.
  • Credit Suisse's ASTEX PHARMACEUTICALS, INC COM position peaked at $5.94M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q4 2013.

Based on Credit Suisse's 13F filing for Q4 2013, filed 14 Feb 2014.